Journal of Gastrointestinal Cancer

, Volume 48, Issue 3, pp 238–240 | Cite as

Global Epidemiology of Hepatocellular Carcinoma (HCC Epidemiology)

  • Aysegul OzakyolEmail author
Review Article

Hepatocellular carcinoma (HCC) is the primary liver cancer derived from hepatocytes and accounts for 85–90% of all primary liver cancers. It is the 5th common cancer in men and the 7th common cancer in women overall in the world [1]. However, it is the third leading cause of cancer-related death, exceeded only by cancers of the lung and stomach. Even HCC is not in the most frequent cancers in the majority of the world, its high mortality and short survival time causes a serious worldwide health burden. Incıdence to mortality rate is 0.95 for HCC and 5 years survival is only 6.9%. Because only a minority of the patients are diagnosed in early stages, overall median survival time is as short as 11 months [2]. Annually, the estimated number of new cases is about 782,000 and causing 600,000 deaths globally per year [1]. HCC burden is not distributed evenly throughout the world. More cases of HCC occur in Asia and Africa than in Western countries and more common in middle- and low-income...


  1. 1.
    Liver Cancer Fact Sheet. Lyon: IARC; International Agency for Research on Cancer. Globocan 2012.Google Scholar
  2. 2.
    Greten TF, Papendorf F, Bleck JS, Kirchhoff T, Wohlberedt T, Kubicka S, et al. Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients. Br J Cancer. 2005;92(10):1862–8.CrossRefGoogle Scholar
  3. 3.
    Liu CJ, Kao JH. Hepatitis B virus-related hepatocellular carcinoma: epidemiology and pathogenic role of viral factors. J Chin med Assoc. 2007;70:141–14520.CrossRefGoogle Scholar
  4. 4.
    Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006;118:3030–44.CrossRefGoogle Scholar
  5. 5.
    Smith JB, Blumberg BS. Viral hepatitis, postnecrotic cirrhosis, and hepatocellular carcinoma. Lancet. 1969;2:953.CrossRefGoogle Scholar
  6. 6.
    Liaw YF, Tai DI, Chu CM, Lin DY, Sheen IS, Chen TJ, et al. Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis. A prospective study. Gastroenterology. 1986;90:263–7.CrossRefGoogle Scholar
  7. 7.
    Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet. 1981;2:1129–33.CrossRefGoogle Scholar
  8. 8.
    Chen CJ, Yang HI, Iloeje UH. Hepatitis B virus DNA levels and outcomes in chronic hepatitis B. Hepatology. 2009;49:S72–84.CrossRefGoogle Scholar
  9. 9.
    Petruzziello A, Marigliano S, Loquercio G, Cozzolino A, Cacciaputio C. Global epidemiology of hepatitis C virus infection: an up-date of the distribution and circulation of hepatitis C virus genotypes. World J Gastroenterol. 2016;22(34):7824–40.CrossRefGoogle Scholar
  10. 10.
    Colombo M, Kuo G, Choo QL, Donato MF, Del Ninno E, Tommasini MA, et al. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet. 1989;2:1006–8.CrossRefGoogle Scholar
  11. 11.
    Frank C, Mohamed MK, Strickland GT, Lavanchy D, ArthurRR MLS, El Khoby T, et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet. 2000;355:887–91.CrossRefGoogle Scholar
  12. 12.
    Mahale P, Torres HA, Kramer JR, Hwang LY, Li R Brown EL, Engels EA. Hepatitis C virus infection and the risk of cancer among elderly US adults: a registry-based case-control study.Cancer 2017 january 24.Google Scholar
  13. 13.
    Mancebo A, González-Diéguez ML, Cadahía V, Varela M, Pérez R, Navascués CA, et al. Annual incidence of hepatocellular carcinoma among patients with alcoholic cirrhosis and identification of risk groups. Clin Gastroenterol Hepatol. 2013;11(1):95–101.CrossRefGoogle Scholar
  14. 14.
    Heckley GA, Jarl J, Asamoah BO, Gerdtham G. How the risk of liver cancer changes after alcohol cessation: a review and meta-analysis of the current literature. BMC Cancer. 2011;11:446.CrossRefGoogle Scholar
  15. 15.
    Groopman JD, Scholl P, Wang JS. Epidemiology of human aflatoxin exposures and their relationship to liver cancer. Prog Clin Biol Res. 1996;395:211–22.PubMedGoogle Scholar
  16. 16.
    Kucukcakan B, Hayrulai-Musliu Z. Challenging role of dietary aflatoxin B1 exposure and hepatitis B infection on risk of hepatocellular carcinoma. J Med Sci. 2015;3(2):363–9.Google Scholar
  17. 17.
    Qian GS, Ross RK, Yu MC, et al. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People’s Republic of China. Cancer Epidemiol Biomark Prev. 1994;3:3–10.Google Scholar
  18. 18.
    Baffy G, Brunt EM, Caldwell SH. Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. J Hepatol. 2012;56(6):1384–91.CrossRefGoogle Scholar
  19. 19.
    Petta S, Craxì A. Hepatocellular carcinoma and non-alcoholic fatty liver disease: from a clinical to a molecular association. Curr Pharm des. 2010;16(6):741–52.CrossRefGoogle Scholar
  20. 20.
    Yeh SH, Chen P. Gender disparity of hepatocellular carcinoma: the roles of sex hormones. J Oncology. 2010;78(Suppl 1):172–9.CrossRefGoogle Scholar
  21. 21.
    Montella M, D'Arena G, Crispo A, Capunzo M, Nocerino F, Grimaldi M, et al. Role of sex hormones in the development and progression of hepatitis B virus-associated hepatocellular carcinoma. Int J Endocrinol. 2015;2015:854530.CrossRefGoogle Scholar
  22. 22.
    Gomaa IA, Khan SA, Toledano MB, Waked I, Taylor-Robinson SD. Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J Gastroenterol. 2008;14(27):4300–8.CrossRefGoogle Scholar
  23. 23.
    Verme G, Brunetto MR, Oliveri F, Baldi M, Forzani B, Piantino P, et al. Role of hepatitis delta virus infection in hepatocellular carcinoma. Dig dis Sci. 1991;36:1134–6.CrossRefGoogle Scholar
  24. 24.
    Bruno S, Crosignani A, Roffi L, De Lisi S, Rossi S, Boccaccio V, et al. SVR is associated with no risk reduction of HCC development in patients with HCV-related cirrhosis. A prospective, up to 23-years, cohort follow-up study. J Hepatology. 2014;60(Suppl):S224.CrossRefGoogle Scholar
  25. 25.
    Goh GB, Chang PE, Tan CK. Changing epidemiology of hepatocellular carcinoma in Asia. Best Pract res Clin Gastroenterol. 2015;29(6):919–28.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2017

Authors and Affiliations

  1. 1.Deparment of GastroenterologyEskisehir Osmangazi UniversityEskisehirTurkey

Personalised recommendations